FRANKLIN COVEY CO. (FC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-05-31..
- Stock-based compensation / revenue · 12 months: Value 2.16%; Formula and calculation Share-based compensation / revenue. Period ending 2026-05-31..
- Interest coverage · 12 months: Value 19.14×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.16% | Share-based compensation / revenue. Period ending 2026-05-31. $5.67M ÷ $262.75M × 100 ≈ 2.16% |
| Interest coverage · 12 months | 19.14× | Operating income ÷ reported interest expense. $6.43M ÷ $336.00K ≈ 19.14× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 262.75M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 5.67M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 6.43M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 336.00K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | (m) | $262.75M | $5.67M | $6.43M | $336.00K | (m) | 2.16% | 19.14× | Reported |
| 2026-02-28 | (m) | $262.06M | $6.38M | $35.00K | $419.00K | (m) | 2.44% | 0.08× | Reported |
| 2025-11-30 | (m) | $262.03M | $5.07M | $578.00K | $482.00K | (m) | 1.93% | 1.20× | Reported |
| 2025-08-31 | (m) | $267.07M | $5.80M | $5.70M | $565.00K | (m) | 2.17% | 10.10× | Reported |
| 2025-05-31 | (m) | $279.94M | $8.78M | $15.74M | $673.00K | (m) | 3.14% | 23.40× | Reported |
| 2025-02-28 | (m) | $286.19M | $9.39M | $26.29M | $783.00K | (m) | 3.28% | 33.58× | Reported |
| 2024-11-30 | (m) | $287.92M | $9.41M | $29.19M | $956.00K | (m) | 3.27% | 30.53× | Reported |
| 2024-08-31 | (m) | $287.23M | $10.14M | $33.04M | $1.12M | (m) | 3.53% | 29.53× | Reported |
| 2024-05-31 | (m) | $281.06M | $10.26M | $25.68M | $1.33M | (m) | 3.65% | 19.37× | Reported |
| 2024-02-29 | (m) | $279.13M | $10.73M | $23.91M | $1.43M | (m) | 3.85% | 16.69× | Reported |
| 2023-11-30 | (m) | $279.55M | $12.68M | $25.30M | $1.51M | (m) | 4.54% | 16.71× | Reported |
| 2023-08-31 | (m) | $280.52M | $12.52M | $26.36M | $1.58M | (m) | 4.46% | 16.65× | Reported |
| 2023-05-31 | (m) | $281.37M | $11.66M | $24.46M | $1.57M | (m) | 4.14% | 15.54× | Reported |
| 2023-02-28 | (m) | $276.11M | $10.72M | $23.83M | $1.63M | (m) | 3.88% | 14.67× | Reported |
| 2022-11-30 | (m) | $270.95M | $9.37M | $24.52M | $1.64M | (m) | 3.46% | 14.96× | Reported |
| 2022-08-31 | (m) | $262.84M | $8.29M | $23.67M | $1.68M | (m) | 3.15% | 14.13× | Reported |
| 2022-05-31 | (m) | $252.98M | $9.48M | $19.32M | $1.74M | (m) | 3.75% | 11.11× | Reported |
| 2022-02-28 | (m) | $245.54M | $9.48M | $16.49M | $1.86M | (m) | 3.86% | 8.87× | Reported |
| 2021-11-30 | (m) | $237.10M | $9.11M | $13.81M | $1.98M | (m) | 3.84% | 6.99× | Reported |
| 2021-08-31 | (m) | $224.17M | $8.62M | $8.10M | $2.10M | (m) | 3.84% | 3.86× | Reported |
| 2021-05-31 | (m) | $204.22M | $6.01M | $7.53M | $2.17M | (m) | 2.94% | 3.47× | Reported |
| 2021-02-28 | (m) | $182.59M | $-1.46M | $4.27M | $2.26M | (m) | -0.80% | 1.89× | Reported |
| 2020-11-30 | (m) | $188.17M | $-1.27M | $3.05M | $2.28M | (m) | -0.67% | 1.34× | Reported |
| 2020-08-31 | (m) | $198.46M | $-573.00K | $3.06M | $2.32M | (m) | -0.29% | 1.32× | Reported |
| 2020-05-31 | (m) | $214.63M | $289.00K | $8.04M | $2.32M | (m) | 0.13% | 3.46× | Reported |
| 2020-02-29 | (m) | $233.53M | $6.44M | $6.33M | $2.27M | (m) | 2.76% | 2.79× | Reported |
| 2019-11-30 | (m) | $230.14M | $5.69M | $3.15M | $2.33M | (m) | 2.47% | 1.35× | Reported |
| 2019-08-31 | (m) | $225.36M | $4.79M | $2.65M | $2.36M | (m) | 2.13% | 1.13× | Reported |
| 2019-05-31 | (m) | $225.01M | $3.70M | $1.53M | $2.51M | (m) | 1.65% | 0.61× | Reported |
| 2019-02-28 | (m) | $219.46M | $3.10M | $805.00K | $2.69M | (m) | 1.41% | 0.30× | Reported |
| 2018-11-30 | (m) | $215.66M | $2.84M | $-767.00K | $2.76M | (m) | 1.32% | -0.28× | Reported |
| 2018-08-31 | (m) | $209.76M | $2.85M | $-3.37M | $2.68M | (m) | 1.36% | -1.26× | Reported |
| 2018-05-31 | (m) | $204.46M | $1.85M | $-3.49M | $2.53M | (m) | 0.91% | -1.38× | Reported |
| 2018-02-28 | (m) | $197.75M | $2.62M | $-7.40M | $2.40M | (m) | 1.32% | -3.08× | Reported |
| 2017-11-30 | (m) | $193.40M | $3.40M | $-6.76M | $2.34M | (m) | 1.76% | -2.89× | Reported |
| 2017-08-31 | (m) | $185.26M | $3.66M | $-8.88M | $2.41M | (m) | 1.97% | -3.69× | Reported |
| 2017-05-31 | (m) | $190.56M | $4.19M | $-2.75M | $2.46M | (m) | 2.20% | -1.11× | Reported |
| 2017-02-28 | (m) | $191.55M | $4.02M | $2.49M | $2.41M | (m) | 2.10% | 1.03× | Reported |
| 2016-11-26 | (m) | $194.62M | $3.57M | $6.71M | $2.34M | (m) | 1.84% | 2.87× | Reported |
| 2016-08-31 | (m) | $200.06M | $3.12M | $13.85M | $2.26M | (m) | 1.56% | 6.12× | Reported |
| 2016-05-28 | (m) | $202.67M | $3.86M | $13.59M | $2.19M | (m) | 1.90% | 6.20× | Reported |
| 2016-02-27 | (m) | $206.24M | $3.40M | $16.26M | $2.16M | (m) | 1.65% | 7.54× | Reported |
| 2015-11-28 | (m) | $207.28M | $2.90M | $17.70M | $2.14M | (m) | 1.40% | 8.28× | Reported |
| 2015-08-31 | (m) | $209.94M | $2.54M | $19.53M | $2.14M | (m) | 1.21% | 9.14× | Reported |
| 2015-05-30 | (m) | $210.61M | $2.28M | $20.52M | $2.17M | (m) | 1.08% | 9.48× | Reported |
| 2015-02-28 | (m) | $209.43M | $2.30M | $22.13M | $2.19M | (m) | 1.10% | 10.10× | Reported |
| 2014-11-29 | (m) | $209.62M | $2.67M | $24.85M | $2.22M | (m) | 1.28% | 11.21× | Reported |
| 2014-08-31 | (m) | $205.16M | $3.53M | $24.77M | $2.24M | (m) | 1.72% | 11.07× | Reported |
| 2014-05-31 | (m) | $198.63M | $4.52M | $19.43M | $2.24M | (m) | 2.27% | 8.67× | Reported |
| 2014-03-01 | (m) | $196.36M | $4.39M | $20.47M | $2.26M | (m) | 2.23% | 9.05× | Reported |
| 2013-11-30 | (m) | $190.28M | $4.38M | $19.83M | $2.30M | (m) | 2.30% | 8.61× | Reported |
| 2013-08-31 | (m) | $190.92M | $3.59M | $21.61M | $2.33M | (m) | 1.88% | 9.27× | Reported |
| 2013-06-01 | (m) | $180.37M | $2.47M | $20.31M | $2.38M | (m) | 1.37% | 8.55× | Reported |
| 2013-03-02 | (m) | $176.78M | $3.04M | $19.64M | $2.41M | (m) | 1.72% | 8.15× | Reported |
| 2012-12-01 | (m) | $174.98M | $3.12M | $19.17M | $2.44M | (m) | 1.78% | 7.86× | Reported |
| 2012-08-31 | (m) | $170.46M | $3.83M | $17.58M | $2.48M | (m) | 2.25% | 7.08× | Reported |
| 2012-05-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-02-25 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-11-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | $160.80M | $2.79M | $11.11M | $2.69M | (m) | 1.73% | 4.14× | Reported |
| 2011-05-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-02-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-11-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | $136.87M | $1.10M | $4.04M | $2.89M | (m) | 0.80% | 1.40× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |